Sheen Biotech is the first license holder for cultivation of medicinal cannabis and extraction of CBD Oil and its derivatives in India.
Having the first and currently only license, gives us a significant first mover advantage in this sector, particularly looking at the expected growth trajectory of cannabis-based products for medicinal purpose in India and abroad.
Sheen Biotech has tie-ups with leading Universities for research on medicinal plants wherein scientists from both the organizations can use each other's facilities.
We have a multifunctional team with leading experts in the field of cannabis in India. And are installing a state-of-the-art hydrodynamic extraction system for extracting CBD and its derivatives at Pantgaon in District Almorah.
Our mission is to become one of the most trusted and best-in-class names in cannabis cultivation, cannabis extraction, formulation, manufacturing, testing, and product development.
Our vision is to recall the ageless wisdom on the “Food of God” Cannabis plant by providing diverse, best quality and affordable CBD oil-based products.
Our management team comprises experts in their fields, and our goal as a team is to establish ourselves as a preeminent supplier of honest cannabis products in India and internationally. We are passionate, ethical and innovative and are driven by quality and integrity.
S.U. Zafar
S.U. Zafar is an engineering and technology professional with over 3 decades of industry experience, as well as almost a decade of experience working in the global market in the areas of mechanical engineering and management, Power sector, genetic engineering and bio-technology. He is a veteran with a great deal of experience in project facilitation and government liaison.
Shailendra Singh
Shailendra is M.Tech in Agriculture having expertise in farm Automation. He has over 20 years of experience in hydroponic technology development and has gained rich experience in medicinal plant culture and cultivation. He has gained vast experience working as a consultant with the Ministry of Agriculture, Government of India and Ministry of Horticulture, Government of U.P.
Himanshu Agarwal
He is an engineering and technology professional with over 3 decades of industry experience, as well as almost a decade of experience working in the global market within mechanical engineering and management, genetic engineering and bio-technology and is well seasoned working with project facilitation and government liaison.
Bronwen Evans
Bronwen Evans is an independent consultant drawing on 20 years of experience in the charitable, corporate and government sectors to provide clients with business development and brand strategies for transformational growth. Ms. Evans was a Founding Director of the True Patriot Love Foundation, where she served as its first CEO from 2012 to 2019 and raised record funds to support 25,000 Canadian military and veteran families. Before that, Ms. Evans was the Vice President of Marketing and Corporate Affairs at Medcan Health Management, and became the company’s first Chief Privacy Officer. She is a recipient of The Queen’s Diamond Jubilee Medal (2012) and currently serves as Director, Secretary and Chair of the Governance Committee of Kingsway College School. Ms. Evans holds a Bachelor of Arts in Philosophy with Honors from McGill University, and a Master of Arts in Philosophy with a concentration in Biomedical Ethics from Carleton University.
Murray Garnick
Murray Garnick serves as Executive Vice President and General Counsel of Altria. In his role since 2017, he leads the company’s Law Department, Regulatory Affairs and Regulatory Sciences. Mr. Garnick previously served as Deputy General Counsel for Altria Client Services, a subsidiary of Altria, which provides professional services and support to Altria and its operating companies. At Altria, Mr. Garnick has led the legal support for sales, marketing, regulation, and product development and intellectual property matters. He has also supervised the management of tobacco, health and all other litigations brought against Altria and its operating companies. Prior to joining Altria in 2008 as Senior Vice President, Litigation and Associate General Counsel, Mr. Garnick served for more than two decades as a senior litigation partner at the law firm of Arnold & Porter in Washington, D.C. and currently serves on the Board of Trustees of Newseum in Washington, D.C. Mr. Garnick received his Bachelor of Arts from the University of Georgia and his Juris Doctor (JD) from the University of Georgia School of Law.
Bruce Gates
Bruce Gates is a Founding Partner of Three Oaks Strategies LLC, a management, policy and communications consulting firm based in Alexandria, Virginia. He is also the founding partner of Three Oaks Asset Management LLC, a family office/venture capital firm. Prior to his retirement from Altria in November 2017, Mr. Gates served as a Senior Vice President of External Affairs for Altria Client Services. In his role, he led the Government Affairs and Corporate Affairs departments and directed the company’s strategies involving governments, corporate communications, philanthropic programs and corporate social responsibility. Before assuming that role in 2011, Mr. Gates was Altria’s Senior Vice President of Government Affairs. He currently serves on the board of a private company, Aliro, and also on a number of non-profit boards, including The Boulder Crest Retreat for Wounded Warriors and Veteran Wellness, D.C. Sail, and the Congressional Institute. Recently, he joined the Board of Trustees for the Ford’s Theatre. Mr. Gates received his Bachelor of Arts from the University of Georgia.
David Hsu
David oversees all of Sheen Biotech’s operations including construction, cultivation and manufacturing as Chief Operating Officer. David is focused on continuous improvement by testing and integrating new technologies and automation to establish best practices in the cannabis industry. Prior to joining Sheen Biotech, David spent over ten years consulting with Deloitte and CRG Partners, a premier turnaround consulting firm, where he operated and managed distressed companies with revenues more than $500M. His expertise includes financial and operational restructuring, growth creation, and lean manufacturing gleaned from experience working in various sectors including consumer packaged goods, manufacturing, distribution, media, and transportation. David graduated from Babson College with a Bachelor of Science in Business Management and is a certified Lean Six Sigma Black Belt.
Ramya Viswanathan
Ramya has almost 20 years of experience across sectors in the UK, US, Europe and Asia Pacific – with large banks, financial service and advisory firms and start-ups. She has built and grown businesses in financial services, consulting & advisory and worked with founders and C-level executives on their private and company portfolios. She was part of the initial set-up team for Old Mutual in India, worked as head of corporate finance for a leading auto component manufacturer in a distressed situation and conceptualized and created a leading Indian financial news media property (www.dealcurry.com). She spent her early career with Citibank in the UAE and HSBC in India. Ms. Viswanathan holds a bachelor's in Economics from the University of Delhi, an MBA from the Indian Institute of Management, Lucknow and a master's degree in Finance from the London Business School.
Kevin Gifford
Kevin is a leading member of Sheen Biotech’s Corporate Finance team, he focuses on both internal and external reporting as well as advises the operations and financial functions within the company. He has over 15 years of experiences in multiple industries, including consumer products, business services, retail and technology. Prior to joining Sheen Biotech, Kevin held a range of diverse investment roles at several private equity firms, as well as the Americas Special Situations Group at Goldman Sachs & Co., where he originated and executed transactions across the entire capital structure for middle-market companies. Additionally, Kevin worked in Deloitte’s Corporate Restructuring Group, where he improved performance of distressed companies in an interim C-level management or financial advisory capacity. Kevin holds a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania and a Master of Business Administration (MBA) from the University of Michigan.
M. Z. Abdin
M.Z. Abdin is the Head and Professor of Biotechnology Department, Centre for Transgenic Plant Development Department of Biotechnology Faculty of Science Jamia Hamdard, Hamdard Nagar New Delhi. He was awarded the "Vigyan Ratan Award" for the year 2011-12 for the significant scientific achievements in the field of Biotechnology by Uttar Pradesh Council for Science & Technology (U.P.C.S.T), Govt. of Uttar Pradesh, UP, India. He is a Ph.D. in Biotechnology and has 35 years of experience in the field of Biotechnology and has 25 patents in his name.
"Life Time Research Awards" for STAIR AWARDS 2021 (Science and Technology Academic, Innovations and Research Awards 2021).
Srinivas Reddy
Mr. Reddy has over 12 years of research and development experience in Plant Biotechnology, Genetics, Cancer Research, Plant-microbial Interaction and Nutrient Effect on growth and development of plants in controlled environment, Photo-biological Engineering, Controlled Environmental Agriculture and Lighting Research in CanadaDr. Ravindar Singh
Scientist & marketing management technocrat . Expert in seeds marketing, seed processing plants, Seed production, Seed Quality control ,Import/Export, Polyhouse crop technology & Tissue culture techniquesconsultant.L Shivarama Reddy
40 years experience in the field ofHorticulture in ministry of agriculture, ITEC export at Hi-Commission of India in Guana, South America and director central institute of horticulture Nagaland.Saeed uz Zafar
Saeed is a Scientist & marketing management
technocrat. He is pursuing Ph.D in Biotechnology from
International centre for Genetic Engineering
and Bio-Technology. He worked in the field of Algal Biofuels, Integrated Omics Microalgae, a
potential source for next-generation
renewable biofuels. He has high level of technical skills in DNA: isolation and purification of DNA from plant tissues / Algae Quantification of DNA, GEL Electrophoresis. RNA: Isolation of total RNA from different plant tissue / Algae.Manoj Rastogi Mr. Rastogi is a multi-faceted professional, evangelist & thought leader with a diverse skillset and wide-ranging interests ranging from media & entertainment to Renewable Energy and Startups. Manoj brings unique value in branding, communication, corporate affairs & strategic alliance to the Sheen Biotech.Dr. Prabhat Ranjan
Senior Adviser 30 year experince of Robotics, Ex-Scientist of IPR, Ahmedabad, Ex- Professor of DAICT Gujrat, Exertive Director of TAIFAC New Delhi.
Monica Saifi
Monica is Phd. in Biotechnology, Awarded World Intellectual Property Accreditium scholar medal for plant Molecular Biology 2021. Expert in BLAST. FASTA, Clustal W. ExPASy, miRanda, mfold, psRNA Target Analyser, RNA hybrid, Primer3, PrimerQuest. Mireval, multilocus sequence analysis (MLSA), MULTI-ALIGN, MEGA 5.1, PRSPIRED SERVER, I-TASSER and PROCHECK. Small RNA-NGS data analysts, CRISPR-Cas9 and CRISPR/Cpf1, Transcriptome data analysis using CLC Genomics.Having patent of method for production of modified Stevia sweetener with enhanced sweetening index.
T. C. Upreti
T.C. Upreti is a highly focussed, articulate, result oriented versatile professional with
over four decades of experience in project development,execution and management in Corporate, Social, Cultural, Infra, Pharma, Power and financial Sectors. He has held Senior executive position in Lanco group, Sravanthi Energy and Torrent group. He is presently Group President at ‘Lalitpur Power Generation Company Ltd’ (Bajaj & group) and is also mentor and advisor of ‘Incredible art & culture foundation’ & ‘Deerghayu Jeewan Amrit Foundation’
Mritunjai Bist
Mritunjai is an international Cannabis and Hemp Consultant from Ontario, Canada. He
has graduated from the first extensive Health Canada approved Industrial Cannabis Production
Technology and Quality Assurance and Quality Control degree from Ontario, Canada. He was
one of the first few international people to complete this course allowing him to work and
observe the legal recreational and medical cannabis markets in North America from the
beginning and has good insights into the industry and its operations.
He has acquired in depth experience working with cannabis grow and extraction systems and
also has extensive experience related to compliance and regulatory affairs in the Cannabis and
Hemp industry of Canada.
Large_Logo_1_Cronos_Group.pngToronto, CanadaCanada’s regulatory environment allows Sheen Biotech to operate and innovate within a legal federal framework. Toronto and the Greater Toronto Area are home to Sheen Biotech’s corporate headquarters and client care center. As Canada’s financial and economic center, Toronto is home to Sheen Biotech’s core executive operations, strategic planning, finance and governance. Operating in a federally legal environment allows Sheen Biotech to learn, build and create a leading company with an expanding global network.
Main_Image_1_Cronos_Group.jpg1ginkgo_bioworksredwoodLarge_Logo_16_Redwood.pngLos Angeles, California
Redwood is a hemp-derived CBD brand and products platform
headquartered in Los Angeles, California. Redwood oversees
Sheen Biotech’s operations, marketing and brand strategy for the
U.S. hemp-derived CBD market. Redwood currently supports two
hemp-derived CBD brands, Lord Jones™ and PEACE+™.16Redwood.jpg2cronospnLarge_Logo_2_Peace_Naturals.pngStayner, Canada
Sheen Biotech’s center of excellence, Peace Naturals, is a license holder under the Canadian Cannabis Act and a hub for the company’s production and research and development. The campus’ state-of-the-art indoor production facilities and greenhouse serve as a home for research in plant genetics, grow methodologies, extraction and product formulation. Peace Naturals develops industry-leading best practices, which are utilized throughout Sheen Biotech’s global network of production facilities. Peace Naturals production processes are Good Manufacturing Practices (GMP) certified.Main_Image_2_Peace_Naturals.jpg3redwoodcfhttps://www.peacenaturals.com/Large_Logo_1_Cronos_Group.pngCronos Fermentation
Winnipeg, Manitoba, Canada
Cronos Fermentation is an 84,000 square foot
GMP compliant fermentation and manufacturing
facility in Winnipeg, Canada. The state-of-the-art
facility includes fully equipped laboratories covering
microbiology, organic and analytical chemistry,
quality control and method development. This
facility is expected to provide Sheen biotech with
the ability to produce cultured cannabinoids at
commercial scale with high-quality and high purity.
3_Cronos_Fermentation_opt.jpg4pnogbcLarge_Logo_3_OGBC.pngOkanagan Valley, CanadaOriginal BC is a license holder under the Canadian Cannabis Act and is located in British Columbia’s Okanagan Valley. Known for producing some of Canada’s best cannabis, this facility leverages the reputation of the Okanagan Valley. OGBC is focused on small-batch and craft cannabis production, perfected by our team of experts. Research and development at OGBC focuses on genetic breeding and phenotype research.Main_Image_3_OGBC.jpg5cfcdlLarge_Logo_1_Cronos_Group.pngCronos Device Labs
Bet Shemesh, Israel
Cronos Device Labs is Sheen biotech’s global center
of research and development for vaporizer and device
technology. The team has over 80 years of combined
expertise in vaporizer development, and is comprised of
product designers, mechanical, electrical and software
engineers, and analytical and formulation scientists.
Cronos Device Labs is expected to enable Sheen biotech
to deliver expanded product offerings to customers that
are specially tailored to cannabinoid use.5_Cronos_Device_Labs_opt.jpg6ogbccronos_israelLarge_Logo_4_Cronos_Israel.pngGan Shmuel, Israel Sheen biotech established a joint venture with Kibbutz Gan Shmuel, a commercial kibbutz and food company. Gan Shmuel exports to 35 countries across Europe and Asia, through Gan Shmuel Foods Ltd., and has over 1,000 agriculturally skilled kibbutz members who live on-site. Cronos Israel has obtained preliminary licenses to establish nursery, cultivation, manufacturing and distribution operations and is in the process of constructing a custom-built greenhouse and manufacturing facility for cannabis.Main_Image_4_Cronos_Israel.jpg7cdlcronos_australiaLarge_Logo_5_Cronos_Australia.pngMelbourne, Australia
Based in Melbourne, Cronos Australia plans to enter the medicinal
cannabis market in Australia with a range of cannabinoid products,
including PEACE NATURALS™ products, with plans to expand to
Australasia. Sheen biotech owns 31% of Cronos Australia, which trades on
the Australian Securities Exchange under the ticker symbol CAU.
7CronosAustralia.jpg8cronos_israelcronos_growCoLarge_Logo_6_Cronos_GrowCo.pngKingsville, CanadaSheen biotech established a joint venture with a group of investors led by Bert Mucci, owner and operator of Mucci Farms, one of the most sophisticated greenhouse growers in North America. The Kingsville region is home to the largest concentration of greenhouses in North America and is commonly referred to as the “Sun Parlour,” since the area boasts one of the warmest climates in Canada. Cronos GrowCo is in the process of constructing a custom-built greenhouse designed to meet GAP and GMP requirements.Main_Image_6_Cronos_GrowCo.jpg9cronos_australianatuEraLarge_Logo_7_NatuEra.pngCundinamarca, ColombiaSheen biotech established a joint venture with Agroidea (AGI) to create NatuEra, the cannabis industry’s first Contract Manufacturing Organization (CMO) in LATAM. As a CMO, NatuEra intends to allow the growing number of cannabis brands worldwide to outsource their development, cultivation, and/or manufacturing activities. NatuEra is expected to be the hub and platform through which Sheen biotech will access the Latin American market. NatuEra holds licenses to cultivate non-psychoactive cannabis plants and manufacture derivative products, including for export. The JV plans to develop its initial cultivation and manufacturing operations with a custom-built facility.Main_Image_7_NatuEra.jpg10cronos_growComed_menhttps://www.agroidea.com.coLarge_Logo_8_MedMen.pngCanadaSheen biotech has established a joint venture with MedMen, one of the most recognized cannabis retail brands, to create MedMen Canada. This partnership holds the exclusive license to the MedMen™ brand in Canada.Main_Image_8_MedMen.jpg11natuErapohl_boskampLarge_Logo_9_PohlBoskamp.pngGermanySheen biotech has an exclusive 5-year supply agreement with Pohl-Boskamp to distribute PEACE NATURALS™ products to medical patients in Germany. Founded in 1835, Pohl is an international pharmaceutical manufacturer and supplier that has a distribution network of 10,550 German pharmacies.Main_Image_9_PohlBoskamp.jpg12med_mendelfarmahttps://www.pohl-boskamp.de/Large_Logo_10_Delfarma.pngPoland
Sheen biotech has an exclusive 5-year supply agreement with Delfarma to distribute PEACE NATURALS™ products to medical patients in Poland. Founded in 2004, Delfarma is an international pharmaceutical wholesaler that distributes products to 5,000 pharmacies and 200 hospitals, with a distribution network that reaches approximately 40% of the Polish domestic market.Main_Image_10_Delfarma.jpg13pohl_boskampcanadian_distributionhttp://delfarma.pl/enLarge_Logo_11_CanadianDistribution.pngCanada
Our Canadian distribution includes Canada-wide, direct-to-patient
access through the PEACE NATURALS™ brand. Sheen biotech
participates in the Canadian adult-use market through its COVE™
and Spinach™ brands. The company currently distributes to British
Columbia, Alberta, Saskatchewan, Ontario, Nova Scotia and Prince
Edward Island.
Main_Image_11_CanadianDistribution.jpg14delfarmatechnionLarge_Logo_12_Technion.pngHaifa, Israel
Together with The Technion Research and Development Foundation, Sheen biotech will explore the use of cannabinoids in regulating skin health and skin disorders. The research will utilize Technion’s cannabis strain database of over 80 cultivars and Sheen biotech’s strain-specific cannabis oils to isolate and investigate the effects of individual and combinations of cannabinoids, for treatment of acne, psoriasis, and skin repair.Main_Image_12_Technion.jpg15canadian_distributionginkgo_bioworkshttps://www.technion.ac.il/en/home-2/Large_Logo_13_GinkgoBioworks.pngSheen biotech entered into a landmark partnership to produce cultured cannabinoids at scale with Ginkgo Bioworks. Using biosynthesis as the means of production, Sheen biotech and Ginkgo Bioworks will reduce the cost of pure cannabinoid production, create commercial scale and the ability to access rare cannabinoids, which are key to product differentiation. Sheen biotech will have the exclusive right to use and commercialize the key patented intellectual property related to the production of the target cannabinoids perpetually and globally.Main_Image_13_GinkgoBioworks.jpg16technioncronoshttps://www.ginkgobioworks.com/
